Bioterrorism Watch Archives – November 1, 2004
November 1, 2004
View Archives Issues
-
Epidemiologic clues, alert clinicians key to detect covert chemical attack
Drawing upon a real-world lesson from the past, medical toxicologists recently recalled the 1983 Tylenol poisoning case in Chicago as an example of how a bioterrorism attack involving chemicals may begin to unfold. Though product-tampering protections have been improved, disturbing aspects of the case include how easy it was to accomplish and the fact that the perpetrator was never caught. -
Do you know where your alternate care site is?
The Agency for Healthcare Research and Quality (AHRQ) has created a tool to help state and local officials quickly locate alternate health care sites if hospitals are overwhelmed by patients due to a bioterrorism attack or other public health emergency. -
Investment in bioterror refueling public health
The massive public health investment to prepare for bioterrorism is paying for itself in the widespread benefits of an improved public health infrastructure, said Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention. -
Biodefense company pitches novel virus binder to feds
Biodefense firm Aethlon Medical Inc. in San Diego has developed a hemopurifier cartridge is capable of binding and removing a wide variety of bloodborne pathogenic viruses before they can infect cells and organs, according to a report posted on the firms web site. -
Top-down bio plans err on public cooperation
Skeptical about government instructions and concerned about loved ones, many Americans would not follow established plans in the event of a real bioterrorism attack, according to a new study by the Center for the Advancement of Collaborative Strategies in Health at The New York Academy of Medicine. -
Journal Review
Rusnak JM, Kortepeter M, Ulrich R, et al. Laboratory exposures to staphylococcal enterotoxin B. Emerg Infect Dis 2004.